Brief: ICAD, Inc. Announces Sale Of Xoft, Its Brachytherapy Business Line, To Elekta
Oct 23 (Reuters) - ICAD Inc ICAD.O :
* ICAD, INC. ANNOUNCES SALE OF XOFT, ITS BRACHYTHERAPY
BUSINESS
LINE, TO ELEKTA
* ICAD INC - PROPOSED DEAL FOR $5.5 MILLION
Source text for Eikon: ID:nGNX6r5WG4
Further company coverage: ICAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on icad
See all newsIcad Inc Reports Results For The Quarter Ended March 31: Earnings Summary
Brief: iCAD, Inc. Q1 Gross Profit USD 4.2 Million
Icad Inc Expected To Post A Loss Of 6 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP- Cognex, Equifax, Netflix
RadNet falls after $103 million all-stock acquisition to buy iCAD